Abstract:G protein-coupled receptors (GPCRs) represent the largest family of membrane proteins and are important drug targets. GPCRs are allosteric machines that transduce an extracellular signal to the cell by activating heterotrimeric G proteins. Herein, we summarize the recent advancements in the molecular activation mechanism of the c-aminobutyric acid type B (GABAB) and metabotropic glutamate (mGlu) receptors, the most important class C GPCRs that modulate synaptic transmission in the brain. Both are mandatory dimers, this quaternary structure being needed for their function The structures of these receptors in different conformations and in complexes with G proteins have revealed their asymmetric activation. This asymmetry is further highlighted by the recent discovery of mGlu heterodimers, where the eight mGlu subunits can form specific and functional heterodimers. Finally, the development of allosteric modulators has revealed new possibilities for regulating the function of these receptors by targeting the transmembrane dimer interface. This family of receptors never ceases to astonish and serve as models to better understand the diversity and asymmetric functioning of GPCRs. NEW & NOTEWORTHY c-aminobutyric acid type B (GABAB) and metabotropic glutamate (mGlu) receptors form constitutive dimers, which are required for their function. They serve as models to better understand the diversity and activation of G protein-coupled receptors (GPCRs). The structures of these receptors in different conformations and in complexes with G proteins have revealed their asymmetric activation. This asymmetry is further highlighted by the recent discovery of specific and functional mGlu heterodimers. Allosteric modulators can be developed to target the transmembrane interface and modulate the asymmetry.

G Protein-Coupled Receptor Dimerization—What Next?

Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function

GPCR heteromers: An overview of their classification, function and physiological relevance

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization

Allosteric functioning of dimeric class C G-protein-coupled receptors.

Dimerization of chemokine receptors and its novel roles in drug discovery

The Role of Dopamine Receptor Dimer Complexes in the Pathogenesis of Depression

GPCR oligomers in pharmacology and signaling

Receptor Dimerization - Rationale for the Design of Bivalent Ligands

Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Computational approaches for modeling GPCR dimerization.

Design of multivalent ligand targeting G-protein-coupled receptors.

Asymmetric activation of dimeric GABAB and metabotropic glutamate receptors

Why is Dimerization Essential for Class-C GPCR Function? New Insights from Mglur1 Crystal Structure Analysis

Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.

Design of bivalent ligands targeting putative GPCR dimers

GPCR Interaction As a Possible Way for Allosteric Control Between Receptors

Stabilised D R G-protein coupled receptor oligomers identify multi-state β-arrestin complexes

Structural features of the G-protein/GPCR interactions

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding.